European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole

View source ↗

Summary

EMA recommends suspending marketing authorisations for oral ketoconazole due to risk of serious liver injury and lack of sufficient benefit for fungal infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections

Drugs mentioned

• ketoconazole (oral) (ketoconazole)